The global digestive health market was valued at USD 37.93 billion in 2019 and is projected to grow from USD 42.19 billion in 2020 to USD 71.95 billion by 2027, registering a CAGR of 7.9% over the forecast period (2020–2027). In 2019, the Asia Pacific region dominated the market with a 46.48% share. According to our analysis, the global market recorded solid growth of 4.7% in 2020.
The digestive health market is expanding, fueled by the rising incidence of digestive disorders, increasing health awareness, a growing elderly population, and a strong preference for natural and safe products. According to a study published by the National Center for Biotechnology Information (NCBI), approximately 11% of the U.S. population experiences chronic digestive diseases, with prevalence soaring to 35% among those aged 65 and older. As the digestive system is vital to overall health, supporting gut health through dietary supplements and functional foods remains crucial.
Market Segmentation:
The global digestive health market is segmented by ingredient type into probiotics, prebiotics, digestive enzymes/food enzymes, and others. In 2019, the probiotics segment accounted for the largest market share, fueled by increasing consumer demand for products that support gut health. This trend is expected to persist throughout the forecast period, encouraging major market players to invest in probiotic innovations. For instance, in October 2020, Bio-K Plus International Inc., a prominent name in the probiotic and biotech industry, launched Essential, a new line of functional beverages infused with probiotics to address the growing demand for gut health solutions.
Request a Free Sample PDF:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digestive-health-market-104750
List Of Key Companies Profiled:
Yakult Honsha Co., Ltd. (Tokyo, Japan)
Cie Gervais Danone (Paris, France)
Sanofi (Paris, France)
BASF SE (Ludwigshafen, Germany)
Bayer AG (Leverkusen, Germany)
Hansen Holding A/S (Hørsholm, Denmark)
Nestle S.A. (Vevey, Switzerland)
Deerland Probiotics & Enzymes, Inc (United States)
DuPont (Delaware, United States)
Other Prominent Players
Driving Factors:
The rising consumer awareness of gut health has accelerated research and development efforts in digestive health products. A large-scale multinational study conducted in 2020 revealed that over 40% of the global population experiences functional gastrointestinal disorders, significantly affecting quality of life and increasing healthcare utilization. This growing concern is driving demand for natural and safe digestive health solutions. In response, market players are heavily investing in R&D to develop innovative products that address evolving consumer needs. For instance, in November 2020, Australia-based biopharmaceutical company Beroni Group launched Beilemei in China—a probiotic product aimed at supporting intestinal flora balance.
Restraining Factors:
Despite the market's positive momentum, several challenges continue to hinder its growth. One of the key obstacles is the stringent regulatory environment surrounding vitamins and dietary supplements. Under the Dietary Supplement Health and Education Act of 1994, companies are responsible for ensuring the safety and validity of claims made about their products. Additionally, manufacturers must register with the FDA under the Bioterrorism Act before production and distribution, causing delays in product launches. Moreover, rising tax rates—by approximately 5–10% in recent years—have increased the cost burden on manufacturers, further constraining market expansion.
Regional Insights:
In 2019, the Asia Pacific region led the digestive health market, valued at USD 17.63 billion. Robust demand in countries such as China, Japan, and India continues to drive regional dominance. Notably, Yakult Honsha Co., Ltd. sells around 9,540 probiotic drink bottles daily in Japan, reflecting strong consumer preference for digestive health products. Additionally, the rising prevalence of digestive disorders across the region supports continued growth.
North America is expected to hold the second-largest market share, fueled by an aging population facing increasing gastrointestinal issues, the presence of numerous manufacturers, and high consumer awareness.
Meanwhile, Europe is projected to grow steadily, supported by a large patient pool and a rising inclination toward natural and safe digestive health products over pharmaceutical alternatives.
Emerging markets in Latin America and the Middle East & Africa are still in the early stages of development but are poised for growth, driven by increasing consumer spending and greater market penetration by leading industry players.
Key Industry Developments:
October 2020 – Standard Process, a supplement company specializing in whole food-based products, launched GI Stability, a prebiotic-infused dietary supplement.
September 2020 – Prorganiq introduced 24-in-1 Mega Superfoods, an innovative dietary supplement designed to support overall health.